Count | |
| 28 | |
| 2 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 211 | |
| 28 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Reverse Transcriptase Inhibitors/blood/*pharmacokinetics/therapeutic use | 1 |
Reverse Transcriptase Inhibitors/adverse effects/blood/*therapeutic use | 1 |
Reverse Transcriptase Inhibitors/adverse effects/*blood/therapeutic use | 1 |
Reverse Transcriptase Inhibitors/adverse effects/blood/*pharmacokinetics | 1 |
| 2 | |
| 4 | |
| 4 | |
| 10 | |
| 35 | |
| 49 | |
| 6 | |
| 48 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 10 | |
| 6 | |
| 1 | |
| 1 | |
| 6 | |
| 6 | |
| 5 | |
| 1 | |
| 1 | |
| 6 | |
| 3 | |
| 2 | |
| 4 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
Triiodothyronine/analogs & derivatives/*metabolism/*physiology | 1 |
| 62 | |
| 1 | |
| 2 | |
| 2 | |
| 8 | |
| 20 | |
| 11 | |
| 4 | |
| 9 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 3 | |
| 37 | |
| 1 | |
| 1 | |
| 1 | |
| 7 | |
| 2 | |